LION BIOTECHNOLOGIES, INC. ANNUAL REPORT

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

March 28, 2014

Period of Report

December 31, 2013

Accession Number

0001513160-14-000023

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →